A long term financial partner for early stage companies with high growth potential
Financiers of early stage companies with expertise in the capital markets
Who we are Introduction to
Introduction to
Numus
Numus Financial is a venture capital firm and early stage financier based in Halifax, Nova Scotia and has more than 20 years of experience in the capital markets. We partner closely with the companies we invest in while providing operational support and strategic advice.
For Founders & Companies
Numus Financial
We are highly selective firm that invest for the long term, typically only adding 2 new investments per year. Once we invest we stay involved through the ups and downs. It takes time to create value and we expect to be there for the entire journey. We do the heavy lifting on financing, identifying and pitching new investors, financial reporting, regulatory affairs, board and investor communications, all to allow our partners to focus on building the businesses that drives their passion.
For Accredited Investors
Numus Capital
We identity and analyze investment opportunities in early-stage businesses with potential to rapidly scale. Our highly qualified deal team performs qualitative and quantitative analysis of all our investment opportunities that we offer to our clients. We introduce our clients to a wide variety of opportunities that are primarily not available through the public markets. We refer qualified investors to investments that meet regulatory requirements and ensure that our clients’ interest are always put first.
Investment Strategy
Numus invests in and scales early-stage private companies with an objective of taking them public on the Canadian markets in the near term. When we invest in a company, we go far beyond just raising capital. As a financial partner, we support our companies through the highs and lows, and help them to strategically scale to a stage when they are ready to self-sustain themselves on the public markets.
We actively seek start-ups in emerging industries that we believe will shape the future:
Clean Technology & Sustainable Innovation
SaaS
Biotech &
Healthcare
Roll-ups of Fragmented Industries
The Numus
Advantage:
Criteria we look for in
Startups:
Businesses that will benefit from a macro trend driving the company forward
This business or founder is a 'change leader' that believes their innovation will have a material effect on their industry
The trajectory of the business will change with more capital
Connecting
Investors:
Opportunity to invest directly into individual startups – build a custom venture portfolio
Modest fees compared to venture capital funds (no % carry or management fees)
Access to unparalleled private investment opportunities with an anticipated liquidity event on the horizon
Companies are carefully vetted by Numus and undergo stringent due diligence processes
Our Investment Edge
Criteria we look for in Startups
We look for businesses that are generally disruptive in their industries
Businesses that will benefit from a macro trend driving the company forward
This business or founder is a 'change leader' that believes their innovation will have a material effect on their industry
The trajectory of the business will change with more capital
Connecting Investors
Opportunity to invest directly into individual startups – build a custom venture portfolio
Modest fees compared to venture capital funds (no % carry or management fees)
Access to unparalleled private investment opportunities with an anticipated liquidity event on the horizon
Companies are carefully vetted by Numus and undergo stringent due diligence processes
2023
Coverage Reports
Numus Financial is proud to announce the launch of our Coverage Reports service, which provides detailed insights on the portfolio companies we invest in. These reports are designed to help investors make informed decisions about their investment opportunities by providing valuable background information on the issuers. Our team has recently begun creating these reports on an ongoing basis, so be sure to check back for updates as more become available throughout the year. With our Coverage Reports, Numus Financial is committed to empowering our investors with the knowledge and resources they need to succeed.
Latest Report
Sona Nanotech Inc.
September 2023
Sona Nanotech (Sona) explores the therapeutic application of its proprietary Gold Nanorod (GNR) technology for in-human use, thanks to its unique manufacturing technology that eliminates the toxicity of CTAB (a toxin used by other manufacturers).
business Insights
Latest Insights & Issuer News
BECOME A partner
A long term financial partner for early stage companies with high growth potential.
Please, fulfill the form to get a consultation. After processing the data, a personal manager will contact you.
invest with us
Early stage financiers with expertise in the capital markets.
Please, fulfill the form to get a consultation. After processing the data, a personal manager will contact you.